OGN
Organon & Co.
NYSE · Healthcare · Drug Manufacturers - General · US
$13.78
+0.04%Margins
Gross margin
53.0%
EBITDA margin
21.3%
EBIT margin
19.3%
Net margin
3.4%
FCF margin
8.1%
20.8%
Return on equity
1.6%
Return on assets
12.4%
Return on invested capital
0.47x
Asset turnover
$737.0M
Cash from operations
$4.31
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026